Diabetes enhances the efficacy of AAV2 vectors in the retina: therapeutic effect of AAV2 encoding vasoinhibin and soluble VEGF receptor 1
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Diabetes enhances the efficacy of AAV2 vectors in the retina: therapeutic effect of AAV2 encoding vasoinhibin and soluble VEGF receptor 1
Authors
Keywords
-
Journal
LABORATORY INVESTIGATION
Volume 96, Issue 3, Pages 283-295
Publisher
Springer Nature
Online
2015-11-16
DOI
10.1038/labinvest.2015.135
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anti-VEGF Therapy for Diabetic Macular Edema
- (2014) Michael W. Stewart Current Diabetes Reports
- Vasoinhibins regulate the inner and outer blood-retinal barrier and limit retinal oxidative stress
- (2014) David Arredondo Zamarripa et al. Frontiers in Cellular Neuroscience
- Anti-VEGF for the Management of Diabetic Macular Edema
- (2014) Francisco Rosa Stefanini et al. Journal of Immunology Research
- AAV-mediated gene delivery in Dp71-null mouse model with compromised barriers
- (2013) Ophélie Vacca et al. GLIA
- Laser Photocoagulation Enhances Adeno-Associated Viral Vector Transduction of Mouse Retina
- (2013) Si Hyung Lee et al. Human Gene Therapy Methods
- Anti-vascular endothelial growth factor therapy for diabetic macular edema
- (2013) David S. Boyer et al. Therapeutic Advances in Endocrinology and Metabolism
- Hesperidin Prevents Retinal and Plasma Abnormalities in Streptozotocin-Induced Diabetic Rats
- (2012) Xiupu Shi et al. MOLECULES
- Plasma Kallikrein Mediates Retinal Vascular Dysfunction and Induces Retinal Thickening in Diabetic Rats
- (2011) A. Clermont et al. DIABETES
- Novel adeno-associated viral vectors for retinal gene therapy
- (2011) L H Vandenberghe et al. GENE THERAPY
- ACE2 and Ang-(1-7) Confer Protection Against Development of Diabetic Retinopathy
- (2011) Amrisha Verma et al. MOLECULAR THERAPY
- A Computational Tool for Quantitative Analysis of Vascular Networks
- (2011) Enrique Zudaire et al. PLoS One
- Vascular endothelial growth factors and vascular permeability
- (2010) D. O. Bates CARDIOVASCULAR RESEARCH
- High Levels of Serum Prolactin Protect Against Diabetic Retinopathy by Increasing Ocular Vasoinhibins
- (2010) E. Arnold et al. DIABETES
- Preclinical Safety Evaluation of AAV2-sFLT01— A Gene Therapy for Age-related Macular Degeneration
- (2010) Timothy K MacLachlan et al. MOLECULAR THERAPY
- Inhibition of Choroidal Neovascularization in a Nonhuman Primate Model by Intravitreal Administration of an AAV2 Vector Expressing a Novel Anti-VEGF Molecule
- (2010) Michael Lukason et al. MOLECULAR THERAPY
- Changes in cultured endothelial cell glycosaminoglycans under hyperglycemic conditions and the effect of insulin and heparin
- (2009) Juying Han et al. Cardiovascular Diabetology
- Investigation of prolactin-related vasoinhibin in sera from patients with diabetic retinopathy
- (2009) Jakob Triebel et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Changes in Adeno-Associated Virus-Mediated Gene Delivery in Retinal Degeneration
- (2009) Kathleen D. Kolstad et al. HUMAN GENE THERAPY
- Peptide Hormone Regulation of Angiogenesis
- (2009) Carmen Clapp et al. PHYSIOLOGICAL REVIEWS
- Changes of macular and RNFL thicknesses measured by Stratus OCT in patients with early stage diabetes
- (2008) T Oshitari et al. EYE
- Recombinant Adeno-associated Virus Transduction and Integration
- (2008) Brian R Schultz et al. MOLECULAR THERAPY
- The parvovirus capsid odyssey: from the cell surface to the nucleus
- (2008) Carole E. Harbison et al. TRENDS IN MICROBIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now